These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 17169498)

  • 21. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE; Gessner JE
    Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement inhibition keeps mothers calm and avoids fetal rejection.
    Girardi G
    Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
    Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.
    Holers VM; Kulik L
    Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
    Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
    Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
    Peng Q; Li K; Sacks SH; Zhou W
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
    Tiegs G
    Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.
    Jaeschke H
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1083-8. PubMed ID: 16687579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response.
    Peng T; Hao L; Madri JA; Su X; Elias JA; Stahl GL; Squinto S; Wang Y
    J Clin Invest; 2005 Jun; 115(6):1590-600. PubMed ID: 15902311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO; Morgan EL; Goodman MG; Chenoweth DE; Hugli TE
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learned from murine models of mannose-binding lectin deficiency.
    Takahashi K
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1487-90. PubMed ID: 19021581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of complement and perspectives for intervention in ischemia-reperfusion damage.
    Banz Y; Rieben R
    Ann Med; 2012 May; 44(3):205-17. PubMed ID: 21254897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular ischaemia and reperfusion injury.
    Eltzschig HK; Collard CD
    Br Med Bull; 2004; 70():71-86. PubMed ID: 15494470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.
    Rudilla F; Fayolle C; Casares N; Durantez M; Arribillaga L; Lozano T; Villanueva L; Pio R; Sarobe P; Leclerc C; Prieto J; Lasarte JJ
    Vaccine; 2012 Apr; 30(18):2848-58. PubMed ID: 22387222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.